SlateStone Wealth’s Teladoc Health TDOC Stock Holding History

SlateStone Wealth’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,652	Closed	-$2.44M	–	175
2021 Q2	$2.44M	Buy	14,652 +3,614	+33%	+$586K	0.56%	43
2021 Q1	$2.01M	Buy	11,038 +259	+2%	+$60.1K	0.5%	53
2020 Q4	$2.15M	Buy	+10,779	New	+$2.19M	0.54%	52

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

SlateStone Wealth's TDOC Position: Q3 2021 in Review

SlateStone Wealth sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 14,652 shares — an estimated $2.44M sold.

SlateStone Wealth first reported a position in TDOC in Q4 2020 and held it in 3 quarters. The position peaked at $2.44M in Q2 2021. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

SlateStone Wealth reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
SlateStone Wealth sold 14,652 Teladoc Health shares in Q3 2021, an estimated $2.44M.
SlateStone Wealth first reported a position in Teladoc Health in Q4 2020 and held it in 3 quarters.
SlateStone Wealth's Teladoc Health position peaked at $2.44M in Q2 2021.
761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on SlateStone Wealth's 13F filing for Q3 2021, filed 28 Oct 2021.